top of page

2026 Agenda: Positioning Therapies Across the GI Spectrum

FRIDAY, JUNE 26, 2026
Moderator: Stephen Hanauer, MD

7:30 AM - 8:15 AM:                 Industry-Sponsored Event & Breakfast
8:40 AM - 8:45 AM:                 Welcome to GI ReConnect
                                               Stephen Hanauer, MD
8:45 AM - 9:05 AM:                 Moderate-Severe IBD: Gateway to Effective Therapies
                                               Stephen Hanauer, MD
9:05 AM - 9:25 AM:                 Moderate-Severe Ulcerative Colitis
9:25 AM - 9:45 AM:                 Acute Severe Ulcerative Colitis
9:45 AM - 10:05 AM:               Moderate-Severe Ileal Crohn's Disease
10:05 AM - 10:25 AM:             Moderate-Severe Ileocolonic Crohn's Disease
                                               Gary Lichtenstein, MD
10:25 AM - 10:40 AM:             Panel Discussion and Q&A
10:40 AM - 11:00 AM:              Exhibit Hall Break
11:00 AM - 11:20 AM:              Treatment of Post-Operative Crohn's Disease
11:20 AM - 11:40 AM:              Antibiotic-Dependent Pouchitis
11:40 AM - 12:00 PM:             How Do Perianal Fistula Change Your Approach to Medical Therapy?
12:00 AM - 12:20 PM:             How Do Extra-Intestinal Manifestations Change Your Approach to IBD Therapies?
12:20 AM - 12:40 PM:             How Do You Dose-Escalate or Switch MOAs?
12:40 AM - 12:55 PM:             Panel Discussion and Q&A
12:55 AM - 1:25 PM:               Exhibit Hall Break
1:25 AM - 2:05 PM:                 Industry-Sponsored Event & Lunch

SATURDAY, JUNE 27, 2026
Moderator: William Chey, MD

7:30 AM - 8:15 AM:                   Industry-Sponsored Event & Breakfast
8:45 AM - 8:50 AM:                   Welcome Back to GI ReConnect
                                                  Darren Brenner, MD
8:50 AM - 9:10 AM:                   All Roads Lead Back to Rome: Key Rome V Updates from A Decade of Discovery
                                                  Lin Chang, MD
9:10 AM - 9:30 AM:                   Complimentary and Integrative Treatment Strategies for DGBIs: Evidence for                                                                                    What's Useful and Useless
9:30 AM - 9:50 AM:                   Neuromodulators for DGBIs: 1st Line or Last Ditch Effort
9:50 AM - 10:10 AM:                 Cost-Effective Diagnostic and Therapeutic Strategies in DGBI
10:10 AM - 10:25 AM:               Panel Discussion and Q&A
10:25 AM - 10:50 AM:               Exhibit Hall Break
10:50 AM - 11:10 AM:               GLPs in GI Disease: The Good, The Bad, and The Unknown
11:10 AM - 11:30 AM:               EoE and EGID: Food? Pharma? Both?
11:30 AM - 11:50 PM:               What's Dripping Through the IBS Pipeline: Potential Future Therapies
11:50 AM - 12:10 PM:               I Refuse to Take a Laxative! Alternative Options for CIC
                                                 Darren Brenner, MD
12:10 PM - 12:30 PM:              Motility Diagnostics: Boldly Going Where No Testing Has Gone Before
12:30 AM - 12:45 PM:              Panel Discussion and Q&A
12:45 AM - 1:15 PM:                Grab Lunch
1:15 AM - 2:00 PM:                  Industry-Sponsored Event & Lunch

bottom of page